Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Despite Quiet Quarter Stock Edges Lower Innventure Inc Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Limited Revenue Disclosure Upstream Bio Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress APAM Q1 2026 Earnings EPS Miss Highlights Margin Pressure Despite Steady AUM Growth Aemetis Inc AMTX Q1 2026 Earnings EPS Misses Estimates Despite Stock Surge Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip